1. Home
  2. ASM vs TBPH Comparison

ASM vs TBPH Comparison

Compare ASM & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASM
  • TBPH
  • Stock Information
  • Founded
  • ASM 1968
  • TBPH 2013
  • Country
  • ASM Canada
  • TBPH United States
  • Employees
  • ASM N/A
  • TBPH N/A
  • Industry
  • ASM Metal Mining
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASM Basic Materials
  • TBPH Health Care
  • Exchange
  • ASM Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • ASM 612.8M
  • TBPH 699.0M
  • IPO Year
  • ASM N/A
  • TBPH N/A
  • Fundamental
  • Price
  • ASM $4.24
  • TBPH $13.95
  • Analyst Decision
  • ASM Strong Buy
  • TBPH Strong Buy
  • Analyst Count
  • ASM 3
  • TBPH 3
  • Target Price
  • ASM $3.73
  • TBPH $21.33
  • AVG Volume (30 Days)
  • ASM 5.6M
  • TBPH 602.7K
  • Earning Date
  • ASM 08-13-2025
  • TBPH 08-12-2025
  • Dividend Yield
  • ASM N/A
  • TBPH N/A
  • EPS Growth
  • ASM 1940.36
  • TBPH N/A
  • EPS
  • ASM 0.11
  • TBPH 0.26
  • Revenue
  • ASM $79,639,000.00
  • TBPH $77,205,000.00
  • Revenue This Year
  • ASM $33.26
  • TBPH $78.36
  • Revenue Next Year
  • ASM $27.16
  • TBPH N/A
  • P/E Ratio
  • ASM $43.21
  • TBPH $54.52
  • Revenue Growth
  • ASM 53.08
  • TBPH 24.49
  • 52 Week Low
  • ASM $0.85
  • TBPH $7.88
  • 52 Week High
  • ASM $4.75
  • TBPH $14.55
  • Technical
  • Relative Strength Index (RSI)
  • ASM 56.23
  • TBPH 71.41
  • Support Level
  • ASM $3.66
  • TBPH $13.66
  • Resistance Level
  • ASM $4.30
  • TBPH $14.55
  • Average True Range (ATR)
  • ASM 0.24
  • TBPH 0.46
  • MACD
  • ASM 0.02
  • TBPH -0.02
  • Stochastic Oscillator
  • ASM 52.75
  • TBPH 56.20

About ASM Avino Silver & Gold Mines Ltd. (Canada)

Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: